BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Thermo Fisher Speeds Up Cell Therapy Manufacturing with Next-Gen Gibco™ CTS™ Dynabeads™ Platform

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)...

September 07, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"

In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...

September 06, 2023 | News

ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001

Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...

September 06, 2023 | News

Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial

Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...

September 05, 2023 | News

ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors

ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...

September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

Bayer Expands Finerenone Clinical Program for Heart Failure

Recruiting approximately 15,000 patients, MOONRAKER is expected to be one of the largest heart failure (HF) study programs to date1,2,3,4 Bayer continue...

September 01, 2023 | News

Sirnaomics' STP707 Shows Promise in Phase I Solid Tumor Study

Six cohorts, totaling 50 late-stage cancer patients, received STP707 four times monthly by intravenous infusion at escalating dosages. All cohorts demon...

September 01, 2023 | News

HiRO Boosts G lobal Presence and Operations with Courante Oncology Acquisition

As a reputable boutique CRO with a strong track record of delivering high-quality, expedited clinical trials in the Asia-Pacific, HiRO's acquisit...

September 01, 2023 | News

Elevating Energy Efficiency and Sustainability in the Pharmaceutical Industry

Explore an in-depth conversation with Jackson Seng as he sheds light on the successful partnership between Schneider Electric and Takeda, leading to the es...

August 31, 2023 | News

South Korea's Genexine's Long-Acting Growth Hormone Meets Phase 3 Endpoint

Phase 3 clinical trial in China meets primary endpoint On track to file BLA in China in 2024 The study being conducted by Genexine’s partner in...

August 31, 2023 | News

HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer

The study of savolitinib is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savoli...

August 29, 2023 | News

Zhiyi Biotech Begins Phase 1 Trial of SK10 for Chemo-induced Diarrhea

SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probi...

August 28, 2023 | News

Stay Connected